After Hours Summary: DDD / SHLD +9%, CVTI / SMTC +7%, WSM +5% higher, while TACO / CTRP -6%, BNFT -5% are lower following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SMRT +53.2%, ICON +16.7%, RUBI +13.4%, BKS +10.4% (approved FY19 budget and expects EBITDA of $175 -200 million), ABUS +9.7% (light volume), EVC +9.5% (thinly traded), DDD +8.7%, SHLD +8.7%, FNJN +7.5%, CVTI +7%, SMTC +7%, COGT +6.8%, QTRX +6.6%, WSM +4.7%, NDLS +4.1%, TLRD +3.7%
Companies trading higher in after hours in reaction to news: PTI +23.6% (confirms the FDA granted Orphan Drug Designation for PTI-428, co's cystic fibrosis transmembrane conductance regulator amplifier drug candidate; also reported earnings), SRRA +13.9% (indicated higher after announcing that late-breaking preclinical results for its Chk1 inhibitor, SRA737, have been accepted for presentation in a poster at the American Association of Cancer Research), SVU +10.6% (Supervalu plans to exit Farm Fresh Banner - to sell 21 stores and continues discussions to sell additional Farm Fresh stores), REXX +5.1% (light volume; agreed to sell to XPR certain of its non-operated oil and gas interests in Westmoreland; expects to receive net proceeds of ~$17.2 million), MGA +4.9% (ticking higher -- Magna and Lyft announce a multi-year collaboration in which the companies will jointly fund, develop, and manufacture self-driving systems; Magna will invest $200 mln in Lyft equity), ESIO +2.1% (initiated with Buy and $36 tgt at Stifel), BPMC +1.8% (ticking higher; announces that preliminary data from its Phase 1 clinical trial evaluating BLU-667 for the treatment of RET-altered non-small cell lung cancer, medullary thyroid cancer, and other advanced solid tumors will be presented at AACR Annual Meeting 2018), SRPT +1.6% (following SLDB DMD drug news), SQ +0.9% and INTC +0.7% (following CNBC mention), IIVI +0.4% (initiated with Buy and $55 tgt at DA Davidson)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: TACO -5.6%, CTRP -5.6%, BNFT -5%
Companies trading lower in after hours in reaction to news: SLDB -54.4% (receives notification from the FDA that IGNITE DMD, its Phase I/II clinical trial for SGT-001 microdystrophin gene transfer in Duchenne muscular dystrophy, has been placed on Clinical Hold), SPEX -20.6% (proposes registered public offering of common stock on a 'best efforts' basis), ZEN -2.5% (to offer $500 mln aggregate principal amount of Convertible Senior Notes due 2023), ABM -1.9% (to offer 9,047,741 shares of ABM common stock in an underwritten secondary offering by selling shareholders), VNDA -1.3% (to offer and sell shares of its common stock in an underwritten public offering)